Division of Pediatric Nephrology, Johns Hopkins University, 200 N. Wolfe St., Baltimore, MD 21287, USA.
Pediatr Nephrol. 2011 Jul;26(7):1129-36. doi: 10.1007/s00467-011-1850-9. Epub 2011 Mar 20.
Urologic disorders are the most common cause of chronic kidney disease in children. To determine whether children with urologic etiology of end-stage renal disease (ESRD) fare better than children with ESRD from other causes while on dialysis, we conducted a cross-sectional study of children <18 years receiving peritoneal and hemodialysis in the United States using data from the Centers for Medicare & Medicaid Services 2005 ESRD CPM Project. We compared baseline demographics and the study groups. In multivariate logistic regression analysis of 1,286 subjects, we assessed whether children with urologic disorders had a higher odds of meeting adult KDOQI targets for hemoglobin levels ≥11 g/dl and albumin ≥3.5 BCG/3.2 BCP g/dl. We conducted a subset analysis of 1,136 patients to examine the impact of erythropoietin on hemoglobin targets. Our results did not reveal differences in achievement of adult hemoglobin targets (adjusted OR: 1.27; p value 0.09; CI: 0.97-1.66) or in the subset analysis with erythropoietin (adjusted OR: 1.32; p value 0.06; CI: 0.98-1.78) or albumin targets (adjusted OR: 1.22; p value 0.21; CI: 0.90-1.65) in adjusted analyses. Due to our study's limitations, it is difficult to determine whether this may result from treatment prior to dialysis initiation or treatment effect of dialysis rather than underlying diagnosis.
泌尿科疾病是儿童慢性肾脏病的最常见病因。为了确定患有终末期肾病(ESRD)的泌尿科病因的儿童在接受透析治疗时是否比患有其他病因的 ESRD 儿童的预后更好,我们利用医疗保险和医疗补助服务中心(Centers for Medicare & Medicaid Services)2005 年 ESRD CPM 项目的数据,对美国接受腹膜和血液透析治疗的<18 岁儿童进行了一项横断面研究。我们比较了两组的基线人口统计学特征和研究组。在对 1286 名受试者进行的多变量逻辑回归分析中,我们评估了患有泌尿科疾病的儿童是否具有更高的机会满足成人 KDOQI 目标,即血红蛋白水平≥11 g/dl 和白蛋白≥3.5 BCG/3.2 BCP g/dl。我们对 1136 名患者进行了亚组分析,以检查促红细胞生成素对血红蛋白目标的影响。我们的结果并未显示在达到成人血红蛋白目标方面存在差异(调整后的 OR:1.27;p 值 0.09;95%CI:0.97-1.66),也未显示在使用促红细胞生成素的亚组分析中存在差异(调整后的 OR:1.32;p 值 0.06;95%CI:0.98-1.78)或白蛋白目标(调整后的 OR:1.22;p 值 0.21;95%CI:0.90-1.65)在调整后的分析中。由于我们研究的局限性,很难确定这是否是由于透析前治疗或透析的治疗效果而不是潜在诊断导致的。